» Articles » PMID: 2527849

Regulation of Mitochondrial Matrix PH and Adenosine 5'-triphosphatase Activity During Ischemia in Slow Heart-rate Hearts. Role of Pi/H+ Symport

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1989 Sep 15
PMID 2527849
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

During ischemia in so-called slow heart-rate hearts, there is a marked inhibition of the mitochondrial ATPase mediated by inhibitor protein binding to the enzyme (Rouslin, W., and Pullman, M. E. (1987) J. Mol. Cell. Cardiol. 19, 661-668). This ischemia-induced ATPase inhibition is triggered by a drop in mitochondrial matrix pH (Rouslin, W. (1987) J. Biol. Chem. 262, 3472-3476) which occurs as a result of the cell acidification which develops rapidly during the ischemic process. One effect of the ATPase inhibition is a marked slowing of the net rate of tissue ATP hydrolysis and, thus, a prolongation of cell viability during ischemia. In the present study, we demonstrate that matrix acidification in intact mitochondria from slow heart-rate hearts appears to be mediated by the Pi transporter. Pi/H+ symport appears to be the primary process which mediates matrix acidification and thus ATPase inhibition in intact slow heart-rate heart mitochondria made acidotic in vitro and, presumably, also in mitochondria in situ during the ischemic process. In contrast, intact mitochondria from a so-called fast heart-rate species, which exhibited only a low level of ischemia-induced ATPase inhibition in situ (Rouslin, W. (1987) Am. J. Physiol. 252, H622-H627), failed to exhibit a Pi- and pH-dependent mitochondrial ATPase inhibition mechanism in vitro. The Pi-dependent mitochondrial ATPase inhibition mechanism reported here for slow heart-rate hearts is consistent with a role for Pi as a coordinating signal promoting the conservation of cell ATP during myocardial ischemia.

Citing Articles

Spatial adjustment of bioenergetics, a possible determinant of contractile adaptation and development of contractile failure.

Szibor M, Muhlon M, Doenst T, Pohjoismaki J Front Mol Med. 2024; 3:1305960.

PMID: 39086691 PMC: 11285667. DOI: 10.3389/fmmed.2023.1305960.


Hyperbaric oxygen treatment reveals spatiotemporal OXPHOS plasticity in the porcine heart.

Heidler J, Cabrera-Orefice A, Wittig I, Heyne E, Tomczak J, Petersen B PNAS Nexus. 2024; 3(6):pgae210.

PMID: 38881840 PMC: 11179111. DOI: 10.1093/pnasnexus/pgae210.


Understanding structure, function, and mutations in the mitochondrial ATP synthase.

Xu T, Pagadala V, Mueller D Microb Cell. 2015; 2(4):105-125.

PMID: 25938092 PMC: 4415626. DOI: 10.15698/mic2015.04.197.


Parallel proteomics to improve coverage and confidence in the partially annotated Oryctolagus cuniculus mitochondrial proteome.

White M, Brown D, Sheng S, Cole R, ORourke B, Van Eyk J Mol Cell Proteomics. 2010; 10(2):M110.004291.

PMID: 21036924 PMC: 3033681. DOI: 10.1074/mcp.M110.004291.


An Inhibitor of the F1 subunit of ATP synthase (IF1) modulates the activity of angiostatin on the endothelial cell surface.

Burwick N, Wahl M, Fang J, Zhong Z, Moser T, Li B J Biol Chem. 2004; 280(3):1740-5.

PMID: 15528193 PMC: 1201548. DOI: 10.1074/jbc.M405947200.